Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Total Liabilities
Everything the company owes to creditors and other parties.
Shoulder Innovations, Inc.NYSE: SI
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities falls 33.9% from a year ago
Total liabilities stood at $15M at the end of Q1 FY2026, down 33.9% from a year earlier and up 0.3% from the prior quarter.
Context
- Total liabilities amounted to 9.4% of total assets at the end of Q1 FY2026, down 30.1 pp from a year earlier.
- Total liabilities increased in 1 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether total liabilities keeps falling in the next quarterly balance sheet after a -33.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 14.96M USD
- Year-over-year change
- -84.7%
- 2-year CAGR
- -60.1%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 14.96M | -84.7% |
| FY2024 | 2024-12-31 | 97.78M | +4.0% |
| FY2023 | 2023-12-31 | 94.03M | — |
Total Liabilities vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 total liabilities of $15M is the 9th highest of the 11 companies compared; the peer median is $36.08M.
- Its year-over-year change of -33.9% is the 10th highest of 11, against a peer median of +2.6%.
- Total liabilities amounts to 9.4% of total assets for SI, versus a peer median of 27.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $198.12M | -13.7% | +53.9% | 63.0% | |
| Jun 2026 | $162.49M | +14.8% | +13.4% | 123.0% | |
| Mar 2026 | $137.77M | +4.9% | -3.7% | 55.2% | |
| Mar 2026 | $103.02M | -6.7% | -0.4% | 36.0% | |
| Mar 2026 | $36.9M | -48.7% | +38.5% | 15.7% | |
| Mar 2026 | $35.26M | -26.8% | -16.3% | 95.0% | |
| Mar 2026 | $33.36M | +0.3% | -0.9% | 18.8% | |
| Dec 2025 | $22.43M | +7.4% | -15.6% | 13.8% | |
| Mar 2026 | $15M | -33.9% | — | 9.4% | |
| Mar 2026 | $11.6M | +83.1% | -38.2% | 11.8% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $9.2M | +318.0% | -29.3% | 6.3% |
| Peer median (excluding SI) | $36.08M | +2.6% | -2.3% | 27.4% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.